Abstract
Both reoperation and alternative treatments for thrombo-occlusive disease of saphenous vein grafts have been fraught with a high rate of complications and a low rate of long-term success. We report 2 cases in which thrombo-occlusive saphenous vein graft disease was treated with the aid of abciximab during the intervention and with low-molecular-weight heparin for 7 to 12 days in an outpatient setting.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Batayias G. E., Barboriak J. J., Korns M. E., Pintar K. The spectrum of pathologic changes in aortocoronary saphenous vein grafts. Circulation. 1977 Sep;56(3 Suppl):II18–II22. [PubMed] [Google Scholar]
- Bulkley B. H., Hutchins G. M. Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation. 1977 Jan;55(1):163–169. doi: 10.1161/01.cir.55.1.163. [DOI] [PubMed] [Google Scholar]
- Ceceña F. A., Hoelzinger D. H. Transcatheter therapy of thrombotic-occlusive lesions in saphenous vein grafts. Am J Cardiol. 1996 Jul 1;78(1):31–36. doi: 10.1016/s0002-9149(97)89224-7. [DOI] [PubMed] [Google Scholar]
- Denardo S. J., Morris N. B., Rocha-Singh K. J., Curtis G. P., Rubenson D. S., Teirstein P. S. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts. Am J Cardiol. 1995 Oct 15;76(11):776–780. doi: 10.1016/s0002-9149(99)80225-2. [DOI] [PubMed] [Google Scholar]
- Gold H. K., Garabedian H. D., Dinsmore R. E., Guerrero L. J., Cigarroa J. E., Palacios I. F., Leinbach R. C. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans. Circulation. 1997 Apr 1;95(7):1755–1759. doi: 10.1161/01.cir.95.7.1755. [DOI] [PubMed] [Google Scholar]
- Hirsh J., Levine M. N. Low molecular weight heparin. Blood. 1992 Jan 1;79(1):1–17. [PubMed] [Google Scholar]
- Koopman M. M., Prandoni P., Piovella F., Ockelford P. A., Brandjes D. P., van der Meer J., Gallus A. S., Simonneau G., Chesterman C. H., Prins M. H. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 1996 Mar 14;334(11):682–687. doi: 10.1056/NEJM199603143341102. [DOI] [PubMed] [Google Scholar]
- Levine M., Gent M., Hirsh J., Leclerc J., Anderson D., Weitz J., Ginsberg J., Turpie A. G., Demers C., Kovacs M. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996 Mar 14;334(11):677–681. doi: 10.1056/NEJM199603143341101. [DOI] [PubMed] [Google Scholar]
- Lytle B. W., Loop F. D., Cosgrove D. M., Ratliff N. B., Easley K., Taylor P. C. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985 Feb;89(2):248–258. [PubMed] [Google Scholar]
- de Feyter P. J., Serruys P., van den Brand M., Meester H., Beatt K., Suryapranata H. Percutaneous transluminal angioplasty of a totally occluded venous bypass graft: a challenge that should be resisted. Am J Cardiol. 1989 Jul 1;64(1):88–90. doi: 10.1016/0002-9149(89)90658-9. [DOI] [PubMed] [Google Scholar]